Olfactory Dysfunction in Coronavirus Disease 2019 Patients: Observational Cohort Study and Systematic Review.

Clicks: 231
ID: 108007
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #31 of 293 articles by views in Open forum infectious diseases

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 293 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Olfactory dysfunction (OD) has been reported in coronavirus disease 2019 (COVID-19). However, there are knowledge gaps about the severity, prevalence, etiology, and duration of OD in COVID-19 patients.Olfactory function was assessed in all participants using questionnaires and the butanol threshold test (BTT). Patients with COVID-19 and abnormal olfaction were further evaluated using the smell identification test (SIT), sinus imaging, and nasoendoscopy. Selected patients received nasal biopsies. Systematic review was performed according to PRISMA guidelines. PubMed items from January 1, 2020 to April 23, 2020 were searched. Studies that reported clinical data on olfactory disturbances in COVID-19 patients were analyzed.We included 18 COVID-19 patients and 18 controls. Among COVID-19 patients, 12 of 18 (67%) reported olfactory symptoms and OD was confirmed in 6 patients by BTT and SIT. Olfactory dysfunction was the only symptom in 2 patients. Mean BTT score of patients was worse than controls ( = .004, difference in means = 1.8; 95% confidence interval, 0.6-2.9). Sinusitis and olfactory cleft obstruction were absent in most patients. Immunohistochemical analysis of nasal biopsy revealed the presence of infiltrative CD68 macrophages harboring severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen in the stroma. Olfactory dysfunction persisted in 2 patients despite clinical recovery. Systematic review showed that the prevalence of olfactory disturbances in COVID-19 ranged from 5% to 98%. Most studies did not assess olfaction quantitatively.Olfactory dysfunction is common in COVID-19 and may be the only symptom. Coronavirus disease 2019-related OD can be severe and prolonged. Mucosal infiltration by CD68 macrophages expressing SARS-CoV-2 viral antigen may contribute to COVID-19-related OD.
Reference Key
chung2020olfactoryopen Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Chung, Tom Wai-Hin;Sridhar, Siddharth;Zhang, Anna Jinxia;Chan, Kwok-Hung;Li, Hang-Long;Wong, Fergus Kai-Chuen;Ng, Ming-Yen;Tsang, Raymond King-Yin;Lee, Andrew Chak-Yiu;Fan, Zhimeng;Ho, Ronnie Siu-Lun;Luk, Shiobhon Yiu;Kan, Wai-Kuen;Lam, Sonia Hiu-Yin;Wu, Alan Ka-Lun;Leung, Sau-Man;Chan, Wai-Ming;Ng, Pauline Yeung;To, Kelvin Kai-Wang;Cheng, Vincent Chi-Chung;Lung, Kwok-Cheung;Hung, Ivan Fan-Ngai;Yuen, Kwok-Yung;
Journal Open forum infectious diseases
Year 2020
DOI
10.1093/ofid/ofaa199
URL
Keywords
covid-19 sars-cov-2 anosmia olfactory dysfunction smell impairment

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.